Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

FMO5 anticorps (C-Term)

FMO5 Reactivité: Humain WB Hôte: Lapin Polyclonal RB42789 unconjugated
N° du produit ABIN1881348
  • Antigène Voir toutes FMO5 Anticorps
    FMO5 (Flavin Containing Monooxygenase 5 (FMO5))
    Épitope
    • 15
    • 13
    • 6
    • 6
    • 2
    • 1
    • 1
    • 1
    AA 474-502, C-Term
    Reactivité
    • 45
    • 27
    • 19
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 43
    • 2
    Lapin
    Clonalité
    • 45
    Polyclonal
    Conjugué
    • 15
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp FMO5 est non-conjugé
    Application
    • 38
    • 20
    • 13
    • 13
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This FMO5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 474-502 amino acids from the C-terminal region of human FMO5.
    Clone
    RB42789
    Isotype
    Ig Fraction
    Top Product
    Discover our top product FMO5 Anticorps primaire
  • Indications d'application
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Date de péremption
    6 months
  • Ross, Katzov-Eckert, Dubé, Brooks, Rassekh, Barhdadi, Feroz-Zada, Visscher, Brown, Rieder, Rogers, Phillips, Carleton, Hayden: "Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy." dans: Nature genetics, Vol. 41, Issue 12, pp. 1345-9, (2009) (PubMed).

    Furnes, Feng, Sommer, Schlenk: "Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans." dans: Drug metabolism and disposition: the biological fate of chemicals, Vol. 31, Issue 2, pp. 187-93, (2003) (PubMed).

  • Antigène
    FMO5 (Flavin Containing Monooxygenase 5 (FMO5))
    Autre désignation
    FMO5 (FMO5 Produits)
    Synonymes
    anticorps MGC68633, anticorps MGC108355, anticorps sb:cb1007, anticorps wu:fc05b01, anticorps wu:fk47g04, anticorps 5033418D19Rik, anticorps AI195026, anticorps flavin containing monooxygenase 5 S homeolog, anticorps flavin containing monooxygenase 5, anticorps fmo5.S, anticorps fmo5, anticorps MCYG_00559, anticorps FMO5, anticorps Fmo5
    Sujet
    Metabolic N-oxidation of the diet-derived amino-trimethylamine (TMA) is mediated by flavin-containing monooxygenase and is subject to an inherited FMO3 polymorphism in man resulting in a small subpopulation with reduced TMA N-oxidation capacity resulting in fish odor syndrome Trimethylaminuria. Three forms of the enzyme, FMO1 found in fetal liver, FMO2 found in adult liver, and FMO3 are encoded by genes clustered in the 1q23-q25 region. Flavin-containing monooxygenases are NADPH-dependent flavoenzymes that catalyzes the oxidation of soft nucleophilic heteroatom centers in drugs, pesticides, and xenobiotics. Alternative splicing results in multiple transcript variants.
    Poids moléculaire
    60221
    NCBI Accession
    NP_001138301, NP_001138302, NP_001452
    UniProt
    P49326
Vous êtes ici:
Support technique